Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: Treatment with opioids

Neurology

Volumn 36, Issue 10, 1986, Pages 1363-1366

  Hening, Wayne A ^a   Walters, Arthur ^a   Kavey, Neil ^a   Gidro Frank, Stephen ^a   Côté, Lucien ^a   Fahn, Stanley ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; METHADONE; OPIATE; PARACETAMOL;

CLINICAL ARTICLE; DRUG ANTAGONISM; DRUG DOSE; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; DYSKINESIA; ETIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUSCULOSKELETAL SYSTEM; NERVOUS SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; THERAPY;

DRUG EVALUATION; HUMANS; MALE; MIDDLE AGED; MOVEMENT; NALOXONE; NARCOTICS; PERIODICITY; RESTLESS LEGS SYNDROME; SLEEP; WAKEFULNESS;

EID: 0022477503     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.36.10.1363     Document Type: Article

References (34)

1. Bornstein B. Restless legs. Psychiatria et Neurologia (Basel) 1961;141:165–201,.
2. Ekbom KA. Restless legs. A clinical study. Acta Med Scand 1945;158:1–123.
3. Ekbom KA. Restless legs. A report of 70 new cases. Acta Med Scand 1950;246:64–8.
4. Ekbom KA. Restless legs syndrome. Neurology (Minneap) 1960;10:868–73.
5. Jolivet B. Parasthesies agitantes nocturnes des membres inGrieurs, impatiences, thesis. Paris, 1953.
6. Walters A, Hening W, Kavey N, Gidro-Frank S, Côté L, Fahn S. Restless legs syndrome: a pleomorphic sensorimotor disorder. Abstract. Neurology (Cleveland) 1984;34(suppl 1):129.
7. Boghen D, Peyronnard JM. Myoclonus in familial restless legs syndrome. Arch Neurol 1976;33:368–70.
8. Coleman RM, Pollak CP, Weitzmann ED. Periodic movements in sleep (nocturnal rnyoclonus): relation to sleep disorders. Ann Neurol 1980;8:416–21.
9. Montplaisir J, Godbout R, Boghen D, DeChamplain J, Young S, LaPierre G. Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology 1985;35:130–4.
10. Kales A, Bixler E, Soldato SC, Vela-Bueno A, Caldwell A, Cadiem R. Role of sleep apnea and nocturnal myoclonus. Psychosomatics 1982;23:589–95.
11. Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. In: Fahn S, Marsden CD, Van Woert M, eds. Advances in neurology: myoclonus, vol 43. New York: Raven Press, 1986:295–307.
12. Lugaresi E, Tassinari C, Coccagna G, Ambrosetto C. Particularith cliniques et polygraphiques du syndrome d’impatience des membres infkrieurs. Rev Neurol (Paris) 1965;113:545–55.
13. Walters A, Hening W, Côté L, Fahn S. Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates? In: Fahn S, Marsden CD, Van Woert M, eds. Advances in neurology: myoclonus, vol 43. New York: Raven Press, 1986:309–19.
14. Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Ann Neurol, 1984;15:234–9.
15. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and waking disorders, indications and techniques. Menlo Park, CA: Addison-Wesley, 1982:265–95.
16. Dement WC. Insomnia: clinical indications. In: Walsh JK, Ber-telson AD, Schweitzer PK, eds. Clinical aspects of sleep disorders. St. Louis: Deaconess Hospital, 1983:33–49.
17. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982;39:739.
18. Tnepacz PT, Violette EJ, Sateia MJ. Response to opioids in three patients with restless legs syndrome. Am J Psychiatry 1984;141:993–6.
19. Willis T. De animae brutorum. London: Wells and Scott, 1672:339.
20. Willis T. Two discourses concerning the soul of brutes. Pordage S, trans. London: Dring, Harper, and Leigh 1683:139.
21. Carskadon MA. Basics for polpomnographic monitoring of sleep. In: Guilleminault C, ed. Sleeping and waking disorders, evaluations and techniques. Menlo Park, CA Addison-Wesley, 1982:1–16.
22. Rechstschaffen A, Kales A, eds. A manual of standardized technology, techniques, and scoring systems for sleep stages of human subjects. Los Angeles: UCLA brain information service/brain research institute, 1968.
23. Coleman RM, Bliwise DL, Sabjen N, et al. Epidemiology of periodic movements during sleep. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven Press, 1983:217–29.
24. Cohen MR, Cohen RM, Pick D, Weingartner H, Murphy DL. High-dose naloxone infusions in normals. Arch Gen Psychiatry 1983;40:613–9.
25. Grevert P, Albert LH, Inturissi CE, Goldstein A. Effects of eight-hour naloxone infusions on human subjects,. Biol Psychiatry 1983;18:1375–92.
26. Hoehn-Saric R, Masek BJ. Effects of naloxone on normals and chronically anxious patients. Biol Psychiatry 1981;16:1041–50.
27. Jaffe JH, Martin WR. Narcotic analgesics and antagonists. In: Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. New York: MacMillan, 1975:268–9.
28. Liebowitz MR, Gorman JM, Fyer AJ, Dillon DJ, Klein DF. Effects of naloxone on patients with panic attacks. Am J Psychiatry 1984;141:995–7.
29. Herling S, Woods JH. IV Mini-symposium. Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 1981;28:1571–84.
30. Miller RJ. Multiple opiate receptors for multiple opioid peptides. Med Biol 1982;60:1–6.
31. Pert CB. The opiate receptor. In: Basset EG, Beers RF Jr, eds. Cell membrane receptors for viruses, antigens and antibodies, polypeptide hormones, and small molecules. New York: Raven Press, 1976:435–50.
32. Wood PL. Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharrnacology 1982;21:487–97.
33. Ninkovic M, Hunt SP, Emson PC, Iversen LL. The distribution of multiple opiate receptors in bovine brain. Brain Res 1981;214:163–7.
34. Frost JJ, Dannals RF, Ravert HT, et al. Imaging opiate receptors with positron emission tomography. J Nucl Med 1984;25:p73.